12 Health Care Stocks Moving In Wednesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Wednesday's after-market session, several healthcare stocks experienced significant movements. TransCode Therapeutics (RNAZ) saw a 17.2% increase, Align Tech (ALGN) rose by 13.29% following Q4 earnings, and Revelation Biosciences (REVB) went up by 12.39%. Protagonist Therapeutics (PTGX), Karyopharm Therapeutics (KPTI), and PaxMedica (PXMD) also saw gains. Conversely, Pieris Pharmaceuticals (PIRS), Ocean Biomedical (OCEA), MAIA Biotechnology (MAIA), Ensysce Biosciences (ENSC), Agape ATP (ATPC), and OneMedNet (ONMD) experienced declines.
January 31, 2024 | 9:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Align Tech shares rose by 13.29% to $302.86 following the release of their Q4 earnings.
The positive reaction to Align Tech's Q4 earnings indicates strong performance and could lead to further short-term gains as the market fully digests the results.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Karyopharm Therapeutics stock rose by 7.92% to $0.81 after-market.
Karyopharm Therapeutics' after-market gain could suggest a short-term bullish trend as investors react positively.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 70
POSITIVE IMPACT
Protagonist Therapeutics shares moved up by 11.91% to $27.99, with a market value of $1.6 billion.
The increase in Protagonist Therapeutics' shares may continue in the short term, reflecting the after-market positive momentum.
CONFIDENCE 75
IMPORTANCE 65
RELEVANCE 80
POSITIVE IMPACT
PaxMedica stock increased by 7.53% to $0.55 in the after-market session.
The rise in PaxMedica's stock price indicates a positive investor response which might lead to short-term gains.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 70
POSITIVE IMPACT
Revelation Biosciences shares increased by 12.39% to $9.7 in the after-market session.
The after-market rise for Revelation Biosciences could indicate investor optimism, potentially leading to short-term price appreciation.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
TransCode Therapeutics shares increased by 17.2% to $0.81 in the after-market session.
The significant after-market gain for TransCode Therapeutics suggests positive investor sentiment, which could lead to a short-term continuation of this upward trend.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Agape ATP stock decreased by 6.26% to $0.61 after-market.
The decline in Agape ATP's stock price in the after-market session could suggest a bearish short-term outlook.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 70
NEGATIVE IMPACT
Ensysce Biosciences shares fell by 6.84% to $1.5 after-market.
Ensysce Biosciences' after-market drop may indicate a continuation of negative price action in the short term.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 70
NEGATIVE IMPACT
MAIA Biotechnology shares decreased by 8.01% to $1.38 in the after-market session.
The drop in MAIA Biotechnology's shares could reflect short-term negative sentiment among investors.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 70
NEGATIVE IMPACT
Ocean Biomedical shares fell by 10.16% to $0.51 after-market.
The after-market decline for Ocean Biomedical may suggest a bearish outlook in the short term.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
NEGATIVE IMPACT
OneMedNet stock declined by 5.3% to $1.79 in the after-market session.
OneMedNet's after-market decline may foreshadow further short-term negative price movement.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 70
NEGATIVE IMPACT
Pieris Pharmaceuticals stock fell by 11.7% to $0.16 after-market.
The decline in Pieris Pharmaceuticals' stock price could continue short-term as the after-market session indicates negative sentiment.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80